Brief: Shenzhen Neptunus Interlong Bio-Technique says Fujian FDA withdrew unit's certificate
17/08/2017 15:52
Aug 17 (Reuters) - Shenzhen Neptunus Interlong Bio-technique
Co Ltd 8329.HK :
* Fuzhou Neptunus Fuyao Pharmaceutical, unit of co received
notice from Fujian Food & Drug Administration
* Certificate withdrawal incident will not significantly
affect production, operation of unit & results of co for FY
* Pharmaceutical GMP Certificate of a production line of
unit was withdrawn by Fujian FDA
* Withdrawal of unit's certificate due to its violation of
rules of Good Manufacturing Practice For Drugs
Source text for Eikon: ID:nHKS88vBqP
Further company coverage: 8329.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million